WorldQuant Millennium Advisors’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-117,032
Closed -$1.36M 613
2025
Q2
$1.36M Buy
+117,032
New +$1.07M 0.01% 379
2022
Q2
Sell
-44,090
Closed -$3.35M 357
2022
Q1
$3.35M Buy
+44,090
New +$3.86M 0.08% 230
2021
Q2
Sell
-20,856
Closed -$3.77M 411
2021
Q1
$3.77M Buy
+20,856
New +$3.6M 0.08% 260

Other funds holding TXG

WorldQuant Millennium Advisors's TXG Position: Q3 2025 in Review

WorldQuant Millennium Advisors sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 117,032 shares — an estimated $1.36M sold.

WorldQuant Millennium Advisors first reported a position in TXG in Q1 2021 and held it in 3 quarters. The position peaked at $3.77M in Q1 2021. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

  • WorldQuant Millennium Advisors reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
  • WorldQuant Millennium Advisors sold 117,032 10x Genomics shares in Q3 2025, an estimated $1.36M.
  • WorldQuant Millennium Advisors first reported a position in 10x Genomics in Q1 2021 and held it in 3 quarters.
  • WorldQuant Millennium Advisors's 10x Genomics position peaked at $3.77M in Q1 2021.
  • 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on WorldQuant Millennium Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.